Examination of factors affecting CD38 expression and daratumumab response in multiple myeloma

Akihiro Kitadate

Presentation information

Oral Session

Oral Session 2-9D Multiple Myeloma: Clinical (Prognosis/Biomarker/Salvage Therapy)

Sat. Oct 12, 2019 4:00 PM - 5:00 PM No.9 (Tokyo International Forum, 4F G402)

Chair: Chikako Ohwada (Department of Hematology, Chiba University Hospital)

[OS2-9D-2] Examination of factors affecting CD38 expression and daratumumab response in multiple myeloma

Akihiro Kitadate^1,2, Toshiki Terao¹, Takafumi Tsushima¹, Hiroki Kobayashi¹, Yoshiaki Abe¹, Daisuke Miura¹, Kentaro Narita¹, Masami Takeuchi¹, Naoto Takahashi², Kosei Matsue¹ (1.Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan, 2.Department of Hematology, Nephrology, and Rheumatology. Akita University, Akita, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.